213 related articles for article (PubMed ID: 17083554)
1. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Gelisken F; Ziemssen F; Voelker M; Bartz-Schmidt KU
Acta Ophthalmol Scand; 2006 Dec; 84(6):833-4. PubMed ID: 17083554
[No Abstract] [Full Text] [Related]
2. Retinal pigment epithelial tear after intravitreal bevacizumab injection.
Shah CP; Hsu J; Garg SJ; Fischer DH; Kaiser R
Am J Ophthalmol; 2006 Dec; 142(6):1070-2. PubMed ID: 17157598
[TBL] [Abstract][Full Text] [Related]
3. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
[TBL] [Abstract][Full Text] [Related]
4. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
[TBL] [Abstract][Full Text] [Related]
5. Retinal pigment epithelial tear following intravitreal bevacizumab for choroidal neovascular membrane due to age-related macular degeneration.
Hannan SR; Madhusudhana KC; Lotery AJ; Newsom RS
Br J Ophthalmol; 2007 Jul; 91(7):977-8. PubMed ID: 17576713
[No Abstract] [Full Text] [Related]
6. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
Spandau UH; Jonas JB
Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
[TBL] [Abstract][Full Text] [Related]
7. Retinal pigment epithelial tear after intravitreal ranibizumab.
Bakri SJ; Kitzmann AS
Am J Ophthalmol; 2007 Mar; 143(3):505-7. PubMed ID: 17317396
[TBL] [Abstract][Full Text] [Related]
8. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin).
Nicolò M; Ghiglione D; Calabria G
Eur J Ophthalmol; 2006; 16(5):770-3. PubMed ID: 17061236
[TBL] [Abstract][Full Text] [Related]
9. Retinal pigment epithelium tears following intravitreal ranibizumab therapy.
Kiss C; Michels S; Prager F; Geitzenauer W; Schmidt-Erfurth U
Acta Ophthalmol Scand; 2007 Dec; 85(8):902-3. PubMed ID: 17408387
[TBL] [Abstract][Full Text] [Related]
10. Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin) injections.
Mennel S; Callizo J; Schmidt JC; Meyer CH
Acta Ophthalmol Scand; 2007 Sep; 85(6):689-91. PubMed ID: 17403025
[No Abstract] [Full Text] [Related]
11. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin): optical coherence tomography and fluorescein angiographic findings.
Mathews JP; Jalil A; Lavin MJ; Stanga PE
Eye (Lond); 2007 Jul; 21(7):1004-5. PubMed ID: 17479124
[No Abstract] [Full Text] [Related]
12. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
Bom Aggio F; Eid Farah M; Melo GB
Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
[No Abstract] [Full Text] [Related]
13. Retinal pigment epithelial tear following intravitreal bevacizumab.
Bakri SJ; Patel SP
Eye (Lond); 2007 Mar; 21(3):424-5. PubMed ID: 17187026
[No Abstract] [Full Text] [Related]
14. Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.
Lee GK; Lai TY; Chan WM; Lam DS
Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1225-7. PubMed ID: 17287977
[TBL] [Abstract][Full Text] [Related]
15. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
Carvounis PE; Kopel AC; Benz MS
Am J Ophthalmol; 2007 Mar; 143(3):504-5. PubMed ID: 17317395
[TBL] [Abstract][Full Text] [Related]
16. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration.
Gelisken F; Ziemssen F; Voelker M; Bartz-Schmidt KU; Inhoffen W
Eye (Lond); 2009 Mar; 23(3):694-702. PubMed ID: 18239678
[TBL] [Abstract][Full Text] [Related]
17. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.
Meyer CH; Mennel S; Schmidt JC; Kroll P
Br J Ophthalmol; 2006 Sep; 90(9):1207-8. PubMed ID: 16929069
[No Abstract] [Full Text] [Related]
18. Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD.
Apte RS
Int Ophthalmol; 2007 Feb; 27(1):59-61. PubMed ID: 17415530
[TBL] [Abstract][Full Text] [Related]
19. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration.
Konstantinidis L; Ambresin A; Zografos L; Mantel I
Acta Ophthalmol; 2010 Nov; 88(7):736-41. PubMed ID: 19604160
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.
Wong LJ; Desai RU; Jain A; Feliciano D; Moshfeghi DM; Sanislo SR; Blumenkranz MS
Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
